Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 4.06 M3.18 M5.3 M7.63 M 20.17 M Research & development ———— — Operating income 77.17 M-47.81 M-6.47 M65.91 M 88.81 M Non-Operating Income, Total -80.17 M-226.42 M-156.22 M-91.11 M -553.91 M Interest expense, net of interest capitalized 36.02 M35.6 M34.21 M34.71 M 140.54 M Non-Operating Income, excl. Interest Expenses -116.19 M-262.01 M-190.43 M-125.82 M -694.46 M Unusual income/expense ———— — Pretax income 116.5 M1.27 M33.01 M115.27 M 266.04 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 77.98 M23.72 M56.48 M-4.52 M 153.66 M Discontinued operations ———— — Net income 77.98 M23.72 M56.48 M-4.52 M 153.66 M Dilution adjustment 16.55 M-3.56 M15.18 M-45.36 M -17.19 M Preferred dividends 26.77 M26.74 M26.7 M26.44 M 106.64 M Diluted net income available to common stockholders 67.76 M-6.58 M44.95 M-76.31 M 29.83 M Basic earnings per share (Basic EPS) 0.1-0.010.05-0.08 0.06 Diluted earnings per share (Diluted EPS) 0.08-0.010.05-0.06 0.06 Average basic shares outstanding 461.36 M472.26 M483.41 M479.87 M — Diluted shares outstanding 876.66 M472.26 M929.94 M479.87 M — EBITDA 45.28 M-80.21 M-37.08 M34.82 M -37.19 M EBIT 43.49 M-80.6 M-38 M34.04 M -41.08 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 1.79 M396 K924 K779 K 3.89 M